In pursuit of better ways to test new therapies and further explore the impacts of the unique genetics associated with Down syndrome, researchers have genetically engineered and characterized what is believed to be the first rat model of Down syndrome. A report of their research appeared in The American Journal of Human Genetics.
Scientists have long sought ways to improve medical care for people with Down syndrome, especially those suffering the physical and mental challenges that are hallmarks of the condition. These include a higher risk of heart defects, gastrointestinal problems and difficulties with learning and memory.
“Developing an animal model that shares these features with human Down Syndrome will allow us to test therapeutics more efficiently, with higher odds of developing ones that can work in people,” says the senior author.
At its root, Down syndrome is an outcome of a so-called chromosomal “trisomy,” or tripling. A typical human cell has 23 pairs of chromosomes, which contain genetic instructions that govern its inner workings and how it interacts with the rest of the body. Down syndrome occurs when a person is born with an extra partial or entire copy of the 21st chromosome, a condition called trisomy 21. This extra chromosome’s effects are expressed widely across the body and its impacts vary among individuals.
Rats do not — as humans do — randomly produce offspring with extra 21st chromosomes, so the researchers set out to accomplish a complicated feat of genetic engineering to generate rats with an additional 21st chromosome.
The process included transferring the 21st chromosome from human white blood cells to mouse cells, then to chicken cells, then hamster cells and, finally, into a rat embryo.
At each transfer, the researchers made different genetic modifications, including the addition of a green glowing protein, which under ultraviolet light identified rats with extra 21st chromosomes.
The team then assessed the genetically engineered rats’ cognition and physical characteristics for traits associated with an extra 21st chromosome.
To test the rats’ learning and memory, for example, the researchers conducted standardized maze tests with the genetically engineered rats.
Rats with an extra 21st chromosome took longer to solve the maze than genetically typical rats. They also had a harder time remembering the maze’s solution when challenged to solve the same puzzle over four consecutive days.
Other cognitive tests reflected that, overall, the rats with an extra 21st chromosome were more anxious and hyperactive than rats without the extra chromosome. These results are consistent with assessments in people with Down syndrome, who report having higher rates of anxiety, attention disorders and learning and memory impairments.
In anatomical studies, the researchers also found that a brain structure called the cerebellum was significantly smaller in rats with an extra 21st chromosome. The cerebellum is central to the body’s core functions, including message processing across the brain, and is much smaller in people with Down syndrome.
“There is already progress in developing pharmaceuticals that help the cerebellum grow in mice,” says the author. “If we eventually translate that into medicines for humans, we may be able to help people with Down syndrome improve their learning and memory skills.”
The distinct facial differences in people with Down syndrome — such as flatter faces, almond-shaped eyes and smaller heads — were also present in the rats. While people cannot look at a rat and determine whether its face looks different from a typical rodent, a computer program can measure the differences. The skulls were scanned in a CT machine and the data added to a computer modeling program, which revealed that the rats had shortened snouts. The bones making up these features in the rat skull correspond to those in human skulls that make up the characteristic facial “flattening” in people with Down syndrome.
Finally, 17% of the rats with an extra 21st chromosome had an abnormality of heart ventricles that is similar to one diagnosed in up to 21% of children with Down syndrome.
https://www.hopkinsmedicine.org/news/newsroom/news-releases/scientists-create-novel-genetic-model-of-down-syndrome-in-rats
https://www.cell.com/ajhg/fulltext/S0002-9297(21)00470-5
A novel genetic model of down syndrome in rats
- 1,487 views
- Added
Latest News
Paranoia in the brain
By newseditor
Posted 16 Jun
In-vitro 3D culture of func…
By newseditor
Posted 15 Jun
Neural balance in the brain…
By newseditor
Posted 15 Jun
Antimalarial compounds reli…
By newseditor
Posted 15 Jun
3D imaging of whole human b…
By newseditor
Posted 14 Jun
Other Top Stories
Linking metabolism with the epigenome to control cellular different…
Read more
How allergens cause pain in atopic dermatitis
Read more
Impacts of vegetarian options in cafeterias
Read more
Breaking down processed foods by human gut microbes
Read more
RNA splicing errors mediated by tau linked to Alzheimer's disease
Read more
Protocols
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Analysis of 3D pathology sa…
By newseditor
Posted 08 Jun
Long-term expandable mouse…
By newseditor
Posted 07 Jun
Publications
Membrane to cortex attachme…
By newseditor
Posted 16 Jun
NRG1-ErbB4 signaling in the…
By newseditor
Posted 15 Jun
HPV integration and cervica…
By newseditor
Posted 15 Jun
Cerebral tau pathology in c…
By newseditor
Posted 15 Jun
Cerebral tau pathology in c…
By newseditor
Posted 15 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar